In this thesis, the short- and long-term event study methodology are applied in order to assess whether M&As, in the pharmaceutical industry, create any abnormal return for the acquirer. The majority of the previous research finds a negative abnormal return but the short-term event study seems to generate slightly positive abnormal returns outside the U.S. There is a limited amount of research on the pharmaceutical industry, thus it is important to find out how the pharmaceutical industry specific conditions and other industry factors affect the performance. In the short-term event study, the cumulative abnormal return (CAR) is applied and in the long-term the buy- and hold abnormal return (BHAR) is exercised. The aim is to connect the perf...
A majority of previous studies reveal evidences of negative or no abnormal returns for the bidder/ac...
This thesis focuses on mergers and acquisitions in the European financial industry and the main char...
A majority of previous studies reveal evidences of negative or no abnormal returns for the bidder/ac...
Purpose: The first objective is to find whether M&A create value for pharmaceutical acquiring compan...
This dissertation analyses a sample of 34 bidding companies engaging in German M&A deals within the ...
This thesis builds upon literature that for many decades have examined the possible wealth creation ...
This paper aims to examine the value creation and earnings management from acquisitions in Scandinav...
This thesis builds upon literature that for many decades have examined the possible wealth creation ...
This study is based on 356 completed takeovers in pharma and biotech industries from 1996 to 2012, r...
The purpose of this study is to examine the short- and long-term acquirer profitability of the merge...
Through mergers and acquisitions the pharmaceutical industry has changed in the last years like neve...
This study provides new evidence on the nature of value creation in M&A activity based on a sample o...
This study provides new evidence on the nature of value creation in M&A activity based on a sample o...
The main purpose of this study is to examine if the relationship between a target and an acquiring c...
The Mergers and Acquisitions market represents an important aspect on the corporate envir...
A majority of previous studies reveal evidences of negative or no abnormal returns for the bidder/ac...
This thesis focuses on mergers and acquisitions in the European financial industry and the main char...
A majority of previous studies reveal evidences of negative or no abnormal returns for the bidder/ac...
Purpose: The first objective is to find whether M&A create value for pharmaceutical acquiring compan...
This dissertation analyses a sample of 34 bidding companies engaging in German M&A deals within the ...
This thesis builds upon literature that for many decades have examined the possible wealth creation ...
This paper aims to examine the value creation and earnings management from acquisitions in Scandinav...
This thesis builds upon literature that for many decades have examined the possible wealth creation ...
This study is based on 356 completed takeovers in pharma and biotech industries from 1996 to 2012, r...
The purpose of this study is to examine the short- and long-term acquirer profitability of the merge...
Through mergers and acquisitions the pharmaceutical industry has changed in the last years like neve...
This study provides new evidence on the nature of value creation in M&A activity based on a sample o...
This study provides new evidence on the nature of value creation in M&A activity based on a sample o...
The main purpose of this study is to examine if the relationship between a target and an acquiring c...
The Mergers and Acquisitions market represents an important aspect on the corporate envir...
A majority of previous studies reveal evidences of negative or no abnormal returns for the bidder/ac...
This thesis focuses on mergers and acquisitions in the European financial industry and the main char...
A majority of previous studies reveal evidences of negative or no abnormal returns for the bidder/ac...